logo

Amag Pharmaceuticals Inc. (AMAG)



Trade AMAG now with
  Date
  Headline
6/11/2020 7:05:39 AM AMAG: Edward Myles, Chief Financial And Chief Operating Officer, Is Leaving Company
5/11/2020 7:23:59 AM AMAG Q1 Revenue $68.7 Mln; To Cut Workforce By 30%
4/28/2020 7:16:45 AM AMAG Pharmaceuticals Appoints Scott Myers As President And CEO
3/4/2020 7:14:40 AM AMAG Pharma Reports FY Operating Loss Of $445.5 Mln And Adjusted EBITDA Loss Of $65.0 Mln
10/11/2019 8:06:04 AM AMAG Pharma Announces Publication Of Phase 3 Vyleesi Data In Obstetrics & Gynecology
10/8/2019 8:05:16 AM AMAG Pharma Announces Settlement Agreement With Caligan Partners
9/26/2019 8:17:52 AM Caligan Partners Issues Letter To AMAG Shareholders; Nominates Directors
2/7/2019 7:27:08 AM AMAG Pharmaceuticals Q4 Loss Per Share $0.64 Vs EPS $0.10 Prior Year
1/17/2019 8:04:17 AM AMAG Completes Acquisition Of Perosphere Pharmaceuticals
1/7/2019 7:18:17 AM AMAG Pharma Q4 Expects Total Revenues From Cont. Opns To Be $85 Mln And $90 Mln
11/1/2018 7:23:24 AM AMAG Pharmaceuticals Q3 Net Loss From Cont Ops $64.7 Mln Or $1.88/Shr Vs Loss $155.7 Mln Or $4.41/Shr Last Year
9/26/2018 6:32:21 AM AMAG Pharmaceuticals Acquires Global Rights To Develop And Market Digoxin Immune Fab